Trials & Treatments Digest Archive
More Good News for Lupus at the American College of Rheumatology Meeting
Lupus Research Institute Encouraged by Phase 2 Trial Results of Experimental Drug Epratuzumab
UPDATE 2-UCB, Immunomedics drug shows promise for lupus
Lupus drug passes key test, researchers say
Lupus Research Institute Highly Encouraged by Benlysta™ Trial Results
First Phase 3 Lupus Drug Trial in Decades to Show Effectiveness
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for Benlysta™
Human Genome Seeks To Surprise Doubters With Lupus-Drug Data
HGS Hoping to Survive Final Test of Lupus Drug
Human Genome's Lupus Drug Shows Success in Trials; Shares Jump
Human Genome Sciences - Racing To Cure Lupus
UM Spinoff Lycera To Receive $36 Million Financing
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
Best Selling Cancer Drug Could Become First New Treatment for Lupus in 50 Years
Rituximab Reduces Kidney Inflammation in Patients with Lupus
Clinical trial is halted for lupus drug Riquent
Cephalon pays $30M to license lupus drug
Human Genome Sciences Reports Substantial Progress Toward Commercialization
BioMarin and La Jolla enter Riquent license pact